Iti Garg

机构：Defence Institute of Physiology and Allied Sciences · ORCID：0000-0003-0748-8769

发表论文 91 篇 · 总被引 858 次 · h-index 17

代表论文

• Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet Diabetes & Endocrinology · 被引 41)
• Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial (2024 · The Lancet Child & Adolescent Health · 被引 40)
• Evaluation of altered miRNA expression pattern to predict COVID-19 severity (2023 · Heliyon · 被引 32)
• “Mitochondrial pathogenic mutations and metabolic alterations associated with COVID‐19 disease severity” (2023 · Journal of Medical Virology · 被引 14)
• Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2025 · The Lancet Infectious Diseases · 被引 11)
• Thrombotic complications post liver transplantation: Etiology and management (2024 · World Journal of Critical Care Medicine · 被引 5)